Doximity (NYSE:DOCS – Get Free Report) released its earnings results on Thursday. The company reported $0.46 earnings per share for the quarter, FiscalAI reports. The firm had revenue of $185.05 million during the quarter. Doximity had a return on equity of 24.63% and a net margin of 40.72%.
Doximity Price Performance
Shares of Doximity stock traded down $1.85 on Thursday, hitting $33.40. The stock had a trading volume of 6,367,280 shares, compared to its average volume of 3,014,426. The company has a market capitalization of $6.29 billion, a P/E ratio of 26.51, a P/E/G ratio of 1.62 and a beta of 1.39. Doximity has a twelve month low of $32.66 and a twelve month high of $85.21.
Analysts Set New Price Targets
A number of equities analysts have recently commented on DOCS shares. Barclays raised Doximity to a “strong-buy” rating in a report on Monday, December 8th. Wall Street Zen downgraded Doximity from a “buy” rating to a “hold” rating in a research note on Saturday, January 10th. Weiss Ratings restated a “hold (c+)” rating on shares of Doximity in a research note on Wednesday, December 24th. Zacks Research raised shares of Doximity from a “hold” rating to a “strong-buy” rating in a report on Monday, January 26th. Finally, Wells Fargo & Company raised shares of Doximity from an “equal weight” rating to an “overweight” rating and set a $55.00 price objective for the company in a research note on Tuesday, January 20th. Three research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $55.00.
Doximity Company Profile
Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.
The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.
Recommended Stories
- Five stocks we like better than Doximity
- The day the gold market broke
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Your Bank Account Is No Longer Safe
- What a Former CIA Agent Knows About the Coming Collapse
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
